Crystal form of compound and use thereof
Inventors
Liu, Yu • YAO, Wenhui • WU, Zeqin • Ma, Zhenkun
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present application provides crystal forms A and B of a free base of a compound represented by formula (I), and relates to a use of the crystal forms A and B
Core Innovation
The invention provides crystal form A of the free base of a compound represented by formula (I), characterized by an X-ray powder diffraction pattern with peaks at 2̈ of 5.28, 7.17, 8.50, 10.66, 14.33, 15.84, and 18.60, each with a tolerance of 0.2. Form A represents an anhydrate or non-solvate, whereas form B represents a toluene solvate, and crystal forms C1, C2, and C3 are additionally identified. The background section and the problem being solved are not included in the provided patent content.
The disclosure describes pharmaceutical compositions, kits, and antibacterial treatment uses for the formula (I) free base. Analytical characterization of crystal form A demonstrates high purity and solid-form stability without significant chemical change under tested conditions, alongside lower moisture uptake than the amorphous form and a dynamic vapor sorption profile showing about 3.6% mass change at high relative humidity. Crystallization purification increases crude-material purity while reducing or eliminating several impurities.
Claims Coverage
The provided claims identify one independent claim and principal coverage areas, including dependent claims directed to compositions, treatment uses, and preparation.
Crystal form A of the formula (I) free base
The independent claim covers crystal form A of the free base of the compound represented by formula (I), exhibiting an X-ray powder diffraction pattern with characteristic peaks at 2̈ of 5.280.2, 7.170.2, 8.500.2, 10.660.2, 14.330.2, 15.840.2, and 18.600.2.
Pharmaceutical composition comprising crystal form A
Dependent claims cover a pharmaceutical composition comprising crystal form A, optionally with a pharmaceutically acceptable carrier and a second therapeutic agent.
Antibacterial treatment uses
Dependent claims cover treatment uses directed to specified bacteria and diseases or related disorders, including infections and conditions listed in the claims.
Preparation of crystal form A
A dependent claim covers preparation of crystal form A by crystallization; [procedural detail omitted for safety].
The claims center on crystal form A characterized by specified diffraction peaks and extend to pharmaceutical compositions, antibacterial treatment uses, and preparation of the crystal form.
Stated Advantages
Form A has reported purity of 99.6% and shows lower moisture uptake than the amorphous form.
Form A shows no significant chemical or solid-form change under the tested stability conditions.
Crystallization purification increases crude-material purity and reduces or eliminates several impurities.
Documented Applications
The document describes pharmaceutical compositions and kits containing the formula (I) compound in crystal form A.
The document describes antibacterial treatment uses, including treatment directed to bacteria such as Helicobacter pylori, Mycobacterium tuberculosis, Acinetobacter baumannii, and Clostridium difficile.
The claimed treatment indications include gastritis, gastric ulcer, bacterial vaginosis, diarrhea, pneumonia, and listed respiratory, skin and soft tissue, bone and joint, intra-abdominal, eye, ear, oral, and surgical infections.
Interested in licensing this patent?